Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus

Endocrine

Volumn 44, Issue 3, 2013, Pages 680-687

  Yoo, Hye Jin ^a   Hwang, Soon Young ^a   Hong, Ho Cheol ^a   Choi, Hae Yoon ^a   Yang, Sae Jeong ^a   Lee, Kwan Woo ^b   Nam, Moon Suk ^c   Park, Yong Soo ^d   Woo, Jeong Taek ^e   Kim, Young Seol ^e   Choi, Kyung Mook ^a   Baik, Sei Hyun ^a  

^a Korea University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Inha University School of Medicine   (South Korea)

^d Hanyang University College of Medicine   (South Korea)

^e Kyung Hee University Hospital   (South Korea)

Author keywords

Adipokines; Omentin 1; Type 2 diabetes mellitus; Vascular stiffness

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HEMOGLOBIN A1C; OMENTIN 1; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DETERMINATION; PROTEIN FUNCTION; PULSE WAVE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84890805602     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-9930-1     Document Type: Article

References (31)

1. M. Laakso, Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention. J. Intern. Med. 249(3), 225-235 (2001)
2. G. Fantuzzi, T. Mazzone, Adipose tissue and atherosclerosis: exploring the connection. Arterioscler. Thromb. Vasc. Biol. 27(5), 996-1003 (2007). doi: 10.1161/ATVBAHA.106.131755
3. R. Yang, A. Xu, J. Pray, H. Hu, S. Jadhao, B. Hansen, A. Shuldiner, J. Mc-Lenithan, D. Gong, Cloning of omentin, a new adipocytokine from omental fat tissue in humans. Diabetes (Suppl. 1), A1 (2003)
4. R.Z. Yang, M.J. Lee, H. Hu, J. Pray, H.B. Wu, B.C. Hansen, A.R. Shuldiner, S.K. Fried, J.C. McLenithan, D.W. Gong, Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab. 290(6), E1253-E1261 (2006). doi: 10.1152/ajpendo.00572.2004
5. C.M. de Souza Batista, R.Z. Yang, M.J. Lee, N.M. Glynn, D.Z. Yu, J. Pray, K. Ndubuizu, S. Patil, A. Schwartz, M. Kligman, S.K. Fried, D.W. Gong, A.R. Shuldiner, T.I. Pollin, J.C. McLenithan, Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56(6), 1655-1661 (2007). doi: 10.2337/db06-1506
6. H.Y. Pan, L. Guo, Q. Li, Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res. Clin. Pract. 88(1), 29-33 (2010). doi: 10.1016/j.diabres.2010.01.013
7. B.K. Tan, R. Adya, S. Farhatullah, K.C. Lewandowski, P. O'Hare, H. Lehnert, H.S. Randeva, Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 57(4), 801-808 (2008). doi: 10.2337/db07-0990
8. S. Tsuji, J. Uehori, M. Matsumoto, Y. Suzuki, A. Matsuhisa, K. Toyoshima, T. Seya, Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J. Biol. Chem. 276(26), 23456-23463 (2001). doi: 10.1074/jbc.M103162200
9. Y.A. Suzuki, K. Shin, B. Lönnerdal, Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry 40(51), 15771-15779 (2001)
10. H. Yamawaki, J. Kuramoto, S. Kameshima, T. Usui, M. Okada, Y. Hara, Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem. Biophys. Res. Commun. 408(2), 339-343 (2011). doi: 10.1016/j.bbrc.2011.04.039
11. H. Yamawaki, N. Tsubaki, M. Mukohda, M. Okada, Y. Hara, Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem. Biophys. Res. Commun. 393(4), 668-672 (2010). doi: 10.1016/j.bbrc.2010.02.053
12. J.M. Moreno-Navarrete, F. Ortega, A. Castro, M. Sabater, W. Ricart, J.M. Fernández-Real, Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity (Silver Spring) 19(8), 1552-1559 (2011). doi: 10.1038/oby.2010.351
13. R. Shibata, N. Ouchi, R. Kikuchi, R. Takahashi, K. Takeshita, Y. Kataoka, K. Ohashi, N. Ikeda, S. Kihara, T. Murohara, Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 219(2), 811-814 (2011). doi: 10.1016/j.atherosclerosis.2011.08.017
14. R. Shibata, R. Takahashi, Y. Kataoka, K. Ohashi, N. Ikeda, S. Kihara, T. Murohara, N. Ouchi, Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men. Hypertens. Res. 34(12), 1309-1312 (2011). doi: 10.1038/hr.2011.130
15. H.J. Yoo, S.Y. Hwang, H.C. Hong, H.Y. Choi, S.J. Yang, J.A. Seo, S.G. Kim, N.H. Kim, K.M. Choi, D.S. Choi, S.H. Baik, Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc. Diabetol. 10, 103 (2011). doi: 10.1186/1475-2840-10-103
16. S.Y. Rhee, S. Chon, M.K. Kwon, B. Park Ie, K.J. Ahn, I.J. Kim, S.H. Kim, H.W. Lee, K.S. Koh, D.M. Kim, S.H. Baik, K.W. Lee, M.S. Nam, Y.S. Park, J.T. Woo, Y.S. Kim, Prevalence of chronic complications in Korean patients with type 2 diabetes mellitus based on the korean national diabetes program. Diabetes Metab. J. 35(5), 504-512 (2011). doi: 10.4093/dmj.2011.35.5.504
17. A. Yamashina, H. Tomiyama, K. Takeda, H. Tsuda, T. Arai, K. Hirose, Y. Koji, S. Hori, Y. Yamamoto, Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens. Res. 25(3), 359-364 (2002)
18. M. Pardo, A. Roca-Rivada, L.M. Seoane, F.F. Casanueva, Obesidomics: contribution of adipose tissue secretome analysis to obesity research. Endocrine 41(3), 374-383 (2012). doi: 10.1007/s12020-012-9617-z
19. J.N. Fain, H.S. Sacks, B. Buehrer, S.W. Bahouth, E. Garrett, R.Y. Wolf, R.A. Carter, D.S. Tichansky, A.K. Madan, Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots. Int. J. Obes. 32(5), 810-815 (2008). doi: 10.1038/sj.ijo.0803790
20. B.K. Tan, R. Adya, S. Farhatullah, J. Chen, H. Lehnert, H.S. Randeva, Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome. Diabetes 59(12), 3023-3031 (2010). doi: 10.2337/db10-0124
21. S. Maruyama, R. Shibata, R. Kikuchi, Y. Izumiya, T. Rokutanda, S. Araki, Y. Kataoka, K. Ohashi, H. Daida, S. Kihara, H. Ogawa, T. Murohara, N. Ouchi, Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism. J. Biol. Chem. 287(1), 408-417 (2012). doi: 10.1074/jbc.M111.261818
22. X.Y. Duan, P.L. Xie, Y.L. Ma, S.Y. Tang, Omentin inhibits osteoblastic differentiation of calcifying vascular smooth muscle cells through the PI3K/Akt pathway. Amino Acids 41(5), 1223-1231 (2011). doi: 10.1007/s00726-010-0800-3
23. N.R. Van de Veire, R. Djaberi, J.D. Schuijf, J.J. Bax, Non-invasive imaging: non-invasive assessment of coronary artery disease in diabetes. Heart 96(7), 560-572 (2010). doi: 10.1136/hrt.2007.122788
24. A. Tuttolomondo, D. Di Raimondo, R. Di Sciacca, R. Pecoraro, V. Arnao, C. Buttà, G. Licata, A. Pinto, Arterial stiffness and ischemic stroke in subjects with and without metabolic syndrome. Atherosclerosis 225(1), 216-219 (2012). doi: 10.1016/j.atherosclerosis.2012.08.027
25. A. Tuttolomondo, R. Di Sciacca, D. Di Raimondo, A. Serio, G. D'Aguanno, A. Pinto, G. Licata, Arterial stiffness indexes in acute ischemic stroke: relationship with stroke subtype. Atherosclerosis 211(1), 187-194 (2010). doi: 10.1016/j.atherosclerosis.2010.02.010
26. I.B. Wilkinson, C.M. McEniery, Arterial stiffness, endothelial function and novel pharmacological approaches. Clin. Exp. Pharmacol. Physiol. 31(11), 795-799 (2004). doi: 10.1111/j.1440-1681.2004.04074.x
27. R.M. Bruno, G. Penno, G. Daniele, L. Pucci, D. Lucchesi, F. Stea, L. Landini, G. Cartoni, S. Taddei, L. Ghiadoni, S. Del Prato, Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. Diabetologia 55(6), 1847-1855 (2012). doi: 10.1007/s00125-012- 2517-1
28. F. Giallauria, S.M. Ling, C. Schreiber, M. Maggio, V. Shetty, D. Muller, C. Vigorito, L. Ferrucci, S.S. Najjar, Arterial stiffness and bone demineralization: the Baltimore longitudinal study of aging. Am. J. Hypertens. 24(9), 970-975 (2011). doi: 10.1038/ajh.2011.80
29. H. Xie, P.L. Xie, X.H. Luo, X.P. Wu, H.D. Zhou, S.Y. Tang, E.Y. Liao, Omentin-1 exerts bone-sparing effect in ovariectomized mice. Osteoporos. Int. 23(4), 1425-1436 (2012). doi: 10.1007/s00198-011-1697-8
30. M. Assadi, H. Salimipour, S. Akbarzadeh, R. Nemati, S.M. Jafari, A. Bargahi, Z. Samani, M. Seyedabadi, Z. Sanjdideh, I. Nabipour, Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue. PLoS ONE 6(9), e24240 (2011). doi: 10.1371/journal.pone.0024240
31. C. Boydens, N. Maenhaut, B. Pauwels, K. Decaluwé, J. Van de Voorde, Adipose tissue as regulator of vascular tone. Curr. Hypertens. Rep. 14(3), 270-278 (2012). doi: 10.1007/s11906-012-0259-6